Edition:
United Kingdom

Neogenomics Inc (NEO.OQ)

NEO.OQ on NASDAQ Stock Exchange Capital Market

13.47USD
20 Jun 2018
Change (% chg)

-- (--)
Prev Close
$13.47
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
114,765
52-wk High
$13.60
52-wk Low
$7.08

Chart for

About

NeoGenomics, Inc. is an operator of a network of cancer-focused genetic testing laboratories. The Company operates in Laboratory Testing Segment. This segment delivers testing services to hospitals, pathologists, oncologists, other clinicians and researchers. It has laboratory locations in Ft. Myers and Tampa, Florida; Aliso... (more)

Overall

Beta: 0.92
Market Cap(Mil.): $876.44
Shares Outstanding(Mil.): 79.39
Dividend: --
Yield (%): --

Financials

  NEO.OQ Industry Sector
P/E (TTM): -- 28.41 32.74
EPS (TTM): -0.33 -- --
ROI: -2.25 6.42 14.38
ROE: -13.82 10.07 16.08

BRIEF-Neogenomics Reports Q1 Adjusted Earnings Per Share $0.04

* NEOGENOMICS REPORTS REVENUE OF $63.4 MILLION, NET INCOME OF $0.6 MILLION AND ADJUSTED EBITDA OF $9.2 MILLION IN THE FIRST QUARTER OF 2018

01 May 2018

BRIEF-NeoGenomics Announces Executive Appointments

* ‍APPOINTMENT OF GEORGE CARDOZA AS PRESIDENT OF PHARMA SERVICES DIVISION​

20 Mar 2018

BRIEF-NeoGenomics Reports Q4 Adjusted EPS Of $0.05

* NEOGENOMICS REPORTS REVENUE OF $67.8 MILLION ON 18.7% CLINICAL VOLUME GROWTH AND $10.5 MILLION OF ADJUSTED EBITDA IN THE FOURTH QUARTER OF 2017

21 Feb 2018

Earnings vs. Estimates